Cannabis Stocks

cannabis stocks

CPH set to expand in $300M Latin American CBD market

Finfeed Archived Jun 04, 2021

The expansion of its comprehensive distribution agreement with leading nutritional supplements company Route2 Pharm Pvt Ltd, will allow for distribution of Creso Pharma Limited's (ASX: CPH, FRA: 1X8) hemp derived therapeutic products sold under the cannaQIX® and CannaDOL brands into Ecuador.

Revenues up 237%: Creso Pharma delivers strong quarter ahead of OTC listing

Finfeed Archived Apr 30, 2021

There were several highlights to come out of the quarterly report released by Creso Pharma (ASX: CPH) today. CPH is enjoying a sustained run this year with revenues up 237% in the lead up to its US listing, which is expected to occur in the coming weeks.

3 stocks to watch and ... the week that was

Finfeed Archived Apr 09, 2021

The market continues its up and down ride, just have a look at what Dale Gillham says about it below, however there were a few small cap stocks that delivered decent news this week and saw the benefits.

CPH looks to expand its footprint as NY State reaches deal legalise recreational cannabis

Finfeed Archived Apr 06, 2021

Creso Pharma (ASX: CPH) has appointed a US Director of Business Development just as New York State has legalised recreational cannabis. New York State is expected to become one of the largest recreational markets in the US valued at US$4.2BN.

Halucenex agreement to give CPH another leg up in psychedelics

Finfeed Archived Mar 31, 2021

Creso Pharma’s (ASX: CPH) pending acquisition of Halucenex Life Sciences should prove to be an astute move, with Halucenex continuing to rapidly move towards its goal of developing and licensing psychedelic compounds for the pharmaceutical and nutraceutical markets.

CPH to list on the OTC as it expands North American footprint

Finfeed Archived Mar 23, 2021

Creso Pharma (ASX: CPH) today announced it is listing on the OTC market in the USA. Listing on the OTC is expected to unlock significant shareholder value and provides CPH with access to one of the largest investment markets in the world at nominal cost.

The CPH Share Price Seems to Have Stabilised – What’s Next?

Next Investors Jan 19, 2021

Today Creso Pharma (ASX: CPH) reported new and follow up Purchase Orders for its animal health medicinal cannabis products totalling over A$345,000.

Creso Pharma’s shares surge following news of Democratic majority in Senate

Finfeed Archived Jan 08, 2021

Following significant share price movement in response to developments in the US, CPH closed at a high of 26.5c, representing a gain of 44% in a mere 24 hours.

NTI Complete In Vitro Studies on Cannabis Strains, Clinical Trials Await

Finfeed Archived Dec 21, 2020

Neurotech International Ltd (ASX: NTI) has today confirmed the successful completion of in-vitro studies using human brain cells to assess and validate the anti-inflammatory and neuro-modulatory properties of its proprietary DOLCE/NTI cannabis leads.

Creso Pharma’s CBD for pets secures regulatory approval in Latin America

Finfeed Archived Dec 21, 2020

Creso Pharma Limited (ASX: CPH, FRA: 1X8) has secured regulatory approval from the Ministry of Agriculture and Animal Feed in Uruguay (Ministerio de Ganadaria, Agricultura y Pesca) through its commercial partner Adler Laboratories, Uruguay for its line of animal health products, anibidiol®.

Roots widens cannabis footprint in California

Finfeed Archived Dec 11, 2020

Roots Sustainable Agricultural Technologies Limited (ASX: ROO) has secured a Non-binding Letter of Intent (LOI) with smart technology provider, Humboldt CCTV to integrate its proprietary Root Zone Temperature Optimisation (RZTO) technology and revolutionary heat exchange stub product into Humboldt’s Smart Agriculture solution.

Creso Pharma is a step closer to unlocking Australian market

Finfeed Archived Dec 11, 2020

Creso Pharma Limited (ASX:CPH, FRA:1X8) has today announced obtainment of an exclusive Heads of Agreement with leading natural, sustainable health and lifestyle brand supplier Martin & Pleasance Pty Ltd.

Good news for cannabis stocks, but European markets down

Finfeed Archived Dec 04, 2020

Cannabis stocks were celebrating this week, on the news that the United Nation’s Commission for Narcotic Drugs voted to reschedule cannabis. This means cannabis is effectively removed from a list including ‘hard’ drugs, such as heroin.

Changes to OTC cannabis sales just around the corner

Finfeed Archived Nov 26, 2020

The Therapeutic Goods Administration (TGA) will shortly bring down its final decision regarding a major regulatory change in the distribution of cannabidiol (CBD) products in Australia, which could hellp stocks such as Creso Pharma (ASX: CPH).

$2M in repeat purchase orders display Creso Pharma’s growth potential

Finfeed Archived Oct 13, 2020

Creso Pharma Limited (ASX: CPH, FRA: 1X8) has once again strengthened its revenue profile with another repeat purchase order from South African-based Pharma Dynamics.

Canopy Growth Founder Joins a Refreshed, Re-Set and Re-Funded CPH

Next Investors Archived Oct 13, 2020

While Creso Pharma (ASX: CPH) continues to sign purchase orders and has appointed Bruce Linton as an advisor, it is a highly speculative investment, and our intent is to hold for the coming months through to Christmas to see how the company’s strategy plays out.

Creso Pharma to receive $8.92M funding: attracts Canopy Growth cannabis pioneer

Finfeed Archived Oct 07, 2020

World leading cannabis executive Bruce Linton has joined Creso Pharma (ASX: CPH) as a strategic advisor with a mandate to use his industry experience to progress the company’s global expansion.

What does a Kamala Harris Vice Presidency mean for cannabis legalisation?

Finfeed Archived Aug 31, 2020

Joe Biden announced that Kamala Harris is his pick for Vice President, should he win the upcoming US Presidential election in November. But what could a Biden/Harris ticket mean for cannabis legalization?

Page 1 of 8 next >